Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa

PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

November 30, 2014

Conditions
Dystrophic Epidermolysis Bullosa
Interventions
DRUG

Granulocyte Colony Stimulating Factor (GCSF)

G-CSF 10mcg/kg/d SQ for 7 days

Trial Locations (1)

37232

Vanderbilt University, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT01538862 - Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa | Biotech Hunter | Biotech Hunter